These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16890797)

  • 1. Novel agents that target tublin and related elements.
    Rowinsky EK; Calvo E
    Semin Oncol; 2006 Aug; 33(4):421-35. PubMed ID: 16890797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microtubule active agents: beyond the taxane frontier.
    Morris PG; Fornier MN
    Clin Cancer Res; 2008 Nov; 14(22):7167-72. PubMed ID: 19010832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tubulin interacting agents: novel taxanes and epothilones.
    Agrawal NR; Ganapathi R; Mekhail T
    Curr Oncol Rep; 2003 Mar; 5(2):89-98. PubMed ID: 12583825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer therapy with novel tubulin-interacting drugs.
    Kavallaris M; Verrills NM; Hill BT
    Drug Resist Updat; 2001 Dec; 4(6):392-401. PubMed ID: 12030786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical discovery of ixabepilone, a highly active antineoplastic agent.
    Lee FY; Borzilleri R; Fairchild CR; Kamath A; Smykla R; Kramer R; Vite G
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):157-66. PubMed ID: 18347795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on tubulin-binding agents.
    Attard G; Greystoke A; Kaye S; De Bono J
    Pathol Biol (Paris); 2006 Mar; 54(2):72-84. PubMed ID: 16545633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel poliglumex. Cell Therapeutics/Chugai Pharmaceutical.
    Man M; Rugo H
    IDrugs; 2005 Sep; 8(9):739-54. PubMed ID: 16118697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tubulin and microtubules as targets for anticancer drugs.
    Hadfield JA; Ducki S; Hirst N; McGown AT
    Prog Cell Cycle Res; 2003; 5():309-25. PubMed ID: 14593726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges of developing therapeutics that target signal transduction in patients with gynecologic and other malignancies.
    Rowinsky EK
    J Clin Oncol; 2003 May; 21(10 Suppl):175s-186s. PubMed ID: 12743132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclostreptin (FR182877), an antitumor tubulin-polymerizing agent deficient in enhancing tubulin assembly despite its high affinity for the taxoid site.
    Edler MC; Buey RM; Gussio R; Marcus AI; Vanderwal CD; Sorensen EJ; Díaz JF; Giannakakou P; Hamel E
    Biochemistry; 2005 Aug; 44(34):11525-38. PubMed ID: 16114889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microtubule stabilising agents for cancer chemotherapy.
    Zhao Y; Fang WS; Pors K
    Expert Opin Ther Pat; 2009 May; 19(5):607-22. PubMed ID: 19441937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microtubule alterations and resistance to tubulin-binding agents (review).
    Drukman S; Kavallaris M
    Int J Oncol; 2002 Sep; 21(3):621-8. PubMed ID: 12168109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of microtubule dynamics by epothilone B is associated with mitotic arrest.
    Kamath K; Jordan MA
    Cancer Res; 2003 Sep; 63(18):6026-31. PubMed ID: 14522931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epothilones: mechanism of action and biologic activity.
    Goodin S; Kane MP; Rubin EH
    J Clin Oncol; 2004 May; 22(10):2015-25. PubMed ID: 15143095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taxanes in paediatric oncology: and now?
    André N; Meille C
    Cancer Treat Rev; 2006 Apr; 32(2):65-73. PubMed ID: 16497442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel anti-tubulin cytotoxic agents for breast cancer.
    Morris PG; Fornier MN
    Expert Rev Anticancer Ther; 2009 Feb; 9(2):175-85. PubMed ID: 19192956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [TUBB3 role in the response of tumor cells to epothilones and taxanes].
    Marczak A; Rogalska A
    Postepy Hig Med Dosw (Online); 2015 Jan; 69():158-64. PubMed ID: 25661915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microtubule assembly dynamics: an attractive target for anticancer drugs.
    Singh P; Rathinasamy K; Mohan R; Panda D
    IUBMB Life; 2008 Jun; 60(6):368-75. PubMed ID: 18384115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond taxanes: a review of novel agents that target mitotic tubulin and microtubules, kinases, and kinesins.
    Harrison MR; Holen KD; Liu G
    Clin Adv Hematol Oncol; 2009 Jan; 7(1):54-64. PubMed ID: 19274042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epothilones and new analogues of the microtubule modulators in taxane-resistant disease.
    Harrison M; Swanton C
    Expert Opin Investig Drugs; 2008 Apr; 17(4):523-46. PubMed ID: 18363517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.